Abstract Purpose: We previously demonstrated that treating asphyxiated newborn piglets with cyclosporine immediately following resuscitation can improve cardiac and intestinal recovery. However, immediate treatment may not be feasible for a large portion of neonates delivered in peripheral or rural hospitals. Therefore, our objective was to determine if delayed cyclosporine treatment remained effective in treating neonatal asphyxia. We hypothesized that early and delayed cyclosporine treatment would improve cardiac and intestinal recovery during resuscitation of asphyxiated newborn piglets. Methods: Thirty piglets (1-4 days old) were instrumented for continuous monitoring of cardiac output and mesenteric hemodynamics. After stabilization, normocapnic alveolar hypoxia (10-15 % oxygen) was instituted for 2 h followed by reoxygenation with 100 % oxygen for 0.5 h, then 21 % for 5.5 h. Piglets were block-randomized to receive either intravenous bolus of cyclosporine A (10 mg/kg) or normal saline (control) at 5 or 120 min of reoxygenation (early or delayed, respectively; n = 8/group). Myocardial and intestinal lactate concentrations as well as histological examinations were determined. Results: Hypoxic piglets had cardiogenic shock (cardiac output 52 ± 1 % of baseline, mean arterial pressure 32 ± 1 mmHg) and acidosis (pH 6.98 ± 0.1). Although both cyclosporine treatments improved cardiac output (p \ 0.05 vs. controls), only early cyclosporine treatment improved stroke volume and systemic oxygen delivery (p \ 0.05 vs. controls). Left ventricle and intestinal lactate were lowered in both cyclosporine-treated groups (p \ 0.05 vs. controls). Early, but not delayed, cyclosporine treatment also attenuated intestinal injury (p \ 0.05 vs. controls). Conclusion: This study demonstrates that treating asphyxiated newborn piglets with cyclosporine within 2 h of resuscitation is effective with superior cardioprotection and intestinal injury attenuation with early treatment.
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Introduction
Asphyxia is estimated to be the primary cause of death in 23 % of the estimated annual four million newborn deaths worldwide [1] . In survivors, cardiovascular dysfunction of varying severity is estimated to occur in 50-80 % [2] . This may be related to the immature newborn heart adapting to new circulatory patterns and becoming overwhelmed with additional hypoxic stress. Furthermore, the immature newborn heart has been shown to have an increased vulnerability to oxidative stress and apoptosis during resuscitation and/or reoxygenation [3, 4] . Concurrently, hypoxic stress of the gastrointestinal system may lead to intestinal injury resembling necrotizing enterocolitis in up to 20 % of asphyxiated newborns [5] . Currently, no standard clinical treatments exist to protect the immature newborn heart and intestine from hypoxia-reoxygenation (H-R) injury.
Cyclosporine treatment is proposed to minimize the formation of mitochondrial permeability transition pore (MPTP) in cardiomyocytes during reperfusion, hence limiting apoptotic and necrotic cell death [6] . Specifically, cyclosporine has been suggested to bind to cyclophilin D, preventing the interaction of cyclophilin D and less welldefined membrane proteins to form the MPTP [7] . The cardioprotective effects of cyclosporine treatment have been reported in an adult pilot clinical trial, in which intravenous cyclosporine treatment prior to revascularization of occluded coronary arteries reduced myocardial infarct size [8] . Recently, we demonstrated improved cardiac function and mesenteric perfusion with attenuated myocardial and intestinal injuries in asphyxiated newborn piglets treated with a single intravenous cyclosporine bolus immediately following reoxygenation [9, 10] . However, the administration of advanced resuscitative medications during resuscitation of human neonates is usually delivered by specialized neonatal intensive care (NICU) teams. Immediate treatment may not be feasible for a large portion of newborns delivered in rural or peripheral sites, where there may have a delay prior to treatment by the NICU team. Thus, optimal timing of cyclosporine treatment in asphyxiated newborns is important and currently unknown. Therefore, our objective was to determine the optimal timing of intravenous cyclosporine treatment during the resuscitation of asphyxiated newborn piglets. In addition, we aimed to determine if delayed cyclosporine treatment during resuscitation of asphyxiated newborn piglets would improve cardiac function and intestinal recovery. We hypothesized that early and delayed cyclosporine treatment during resuscitation of asphyxiated newborn piglets would improve cardiac recovery and attenuate intestinal injury.
Methods
Thirty newborn mixed breed piglets 1-4 days of age weighing 1.5-2.5 kg were obtained on the day of experimentation from the University Swine Research Technology Centre. All experiments were conducted in accordance with the guidelines and approval of the Animal Care and Use Committee (Health Science), University of Alberta.
Animal preparation
Animal preparation has been previously described [9] . Briefly, following induction of anesthesia, mechanical ventilation was commenced. Fractional inspired oxygen concentrations (FiO 2 ) were continuously measured and maintained between 0.21 and 0.25 to keep SaO 2 between 90 and 100 %. Intravenous fluids consisting of 5 % dextrose in water at 10 ml/kg/h and 0.9 % NaCl at 2 ml/kg/h were used to maintain glucose levels and hydration. Anesthesia was maintained with intravenous fentanyl 5-20 lg/kg/h and midazolam 0.2-1 mg/kg/h and pancuronium 0.05-0.1 mg/kg/h. Additional intravenous doses of fentanyl (10 lg/kg) and acepromazine (0.25 mg/kg) were also given as needed. Piglet body temperature was maintained at 38.5-39.5°C using an overhead warmer and a heating pad.
A 5-French Argyle double-lumen catheter was inserted into the femoral vein, up to the level of the right atrium for administration of fluids and medications. A 5-French Argyle single-lumen catheter was inserted into the femoral artery to the distal aorta and attached to a pressure transducer for continuous systemic measurement of arterial pressure to determine mean arterial pressure (MAP). Heart rate and MAP were measured with a Hewlett Packard 78833B monitor (Hewlett Packard Co., Palo Alto, CA).
Endotracheal intubation via a tracheostomy was performed, and pressure-controlled ventilation (Sechrist infant ventilator model IV-100; Sechrist Industries, Anaheim, CA) was commenced at a respiratory rate of 16-20 breaths/min and pressure of 19/4 cmH 2 O. A left flank incision was used to open the retroperitoneum. The superior mesenteric artery (SMA) was encircled with a 3-mm flow probe (3SB; Transonic Systems Inc, Ithica, NY) to measure SMA blood flow. In the third intercostal space a left anterior thoractomy was preformed and a 6-mm transonic flow probe (6SB) was placed around the main pulmonary artery to measure blood flow, which served as the surrogate of cardiac output. The ductus arteriosus was ligated. A 20G Arrow Ò angiocatheter (Arrow International, Reading, PA) was inserted for the continuous measurement of pulmonary artery pressure. Transonic flow probes and pressure transducer outputs were digitized and recorded by a converter board in a computer equipped with custom Asyst programming software (Data Translation, Ontario, Canada).
Piglets were allowed to recover from surgical instrumentation until baseline hemodynamic measures were stable. Ventilator rate was adjusted to keep the PaCO 2 35-45 mmHg as determined by periodic arterial blood gas analysis. Heart rate, MAP, cardiac output, SMA blood flow, and oxygen saturation were continuously monitored and recorded throughout the experiment.
Experimental protocol
The piglets were block-randomized to three groups (n = 8/group) that underwent H-R. A fourth sham-operated group of piglets (n = 6) underwent complete instrumentation without H-R and delivery of cyclosporine.
Normocapnic alveolar hypoxia was induced in all H-R piglets. These piglets were ventilated with a FiO 2 of 0.11-0.15 by increasing the inhaled concentration of nitrogen gas relative to oxygen for 2 h, aiming for SaO 2 of 40-50 %. It has been shown in previous studies that this degree of hypoxemia in the newborn piglet model will produce clinical asphyxia with severe metabolic acidosis and systemic hypotension [9, 11] . This was followed by reoxygenation with 100 % oxygen for 0.5 h and then 21 % oxygen for 5.5 h. At 5 min and 120 min of reoxygenation, piglets received a blinded treatment either with cyclosporine A as an intravenous bolus (10 mg/kg) or saline (control). Cyclosporine dosing of 10 mg/kg was based on previous dose-finding experiments [9] . Cyclosporine A treatment was given at 5 min reoxygenation to simulate the clinical scenario when intravenous access is obtained in the neonate for the administration of resuscitative medications. In another experimental group, cyclosporine A was given at 120 min reoxygenation to simulate the clinical setting in which resuscitation by the mobile NICU team or transfer to a NICU requires an estimated 2 h following newborn delivery at a peripheral or rural hospital (personal observation).
Medication preparation and delivery
Blinding was maintained by reconstituting cyclosporine A with normal saline to a standard total volume (5 ml) immediately before administration [9] . The medication was given intravenously over 2 min. A laboratory technician uninvolved in the experiment prepared the medications.
Hemodynamic measurements and oxygen transport
Hemodynamic recording for data analysis was carried out at specified time points: baseline, hypoxia (60 and 120 min), and during reoxygenation (10 and 30 min with FiO 2 of 1.0, and 60, 120, 130, 150, 180, 240, 300, 360 min with FiO 2 of 0.21). All recordings were calculated as a mean over 2 min of recording. Hemodynamic variables were calculated as shown in a previous study [11] .
At the specified time points, both arterial and venous blood samples were taken for blood gases, hemoglobin levels, and co-oximetry. The systemic oxygen delivery (DO 2 ), SMA DO 2 , and systemic oxygen consumption (VO 2 ) were calculated using standard formulas [12] .
Arterial blood samples (1 ml) were taken at predetermined intervals coinciding with hemodynamic measurements, centrifuged at 10,0009g for 15 min. The supernatant was then collected and frozen at -80°C for determination of plasma lactate. Less than 5 % of the piglet's blood volume was collected for blood work.
At the end of the study, piglets were euthanized with i.v. 100 mg/kg pentobarbital. Samples of left ventricle and intestine were immediately harvested, snap-frozen in liquid nitrogen, and stored in -80°C for biochemical analysis.
Determination of plasma, left ventricle, and small intestinal lactate
The plasma lactate concentration was determined by a nicotinamide adenine dinucleotide enzyme-coupled colorimetric assay with spectrophotometry at 340 nm at each time point coinciding with hemodynamic measurements.
Tissue lactate, a marker for tissue perfusion and anaerobic metabolism, was measured following H-R. Left ventricle myocardial and small intestinal (ileum) tissues were homogenized with 10 ll/mg of 50 mM phosphate buffer containing 0.5 mM EGTA. Left ventricle and intestinal lactate were assayed by enzymatic spectrometric methods to measure the absorbance of NADH at 340 nm. The protein content was determined by bicinchoninic acid assay kit (Sigma).
Histopathology
Samples of left ventricle and small intestine (ileum) collected at the end of the experiment were fixed in 10 % formalin for histological analysis. Samples were processed for histological assessment using hematoxylin and eosin staining. An independent pathologist (C.S.) blinded to all groups evaluated and graded the histological damage of specimens on the basis of the Rose classification for myocardial injury [13] and Park classification for intestinal injury [14] .
Statistical analysis
Results are expressed as mean ± standard error of mean. Hemodynamic data at various time points expressed in percentage were calculated on the basis of the respective baseline. Hemodynamic and oxygen transport variables were analyzed by two-way repeated measures ANOVA. We used the Student-Newman-Keuls method where appropriate for pairwise comparisons in post hoc testing. Biochemical markers were analyzed by two-way repeated measures ANOVA or one-way ANOVA as appropriate. If the normality test failed, ANOVA on ranks (KruskalWallis) was performed. Pearson moment correlation was used. Significance was defined as p less than 0.05.
Results
The piglets were 2.4 ± 1.1 days old and weighed 1.8 ± 0.3 kg with no significant differences among groups. There was no significant difference among groups at baseline in arterial blood gases (Table 1 ) and all hemodynamic variables (Supplementary Table 1 ). Shamoperated animals were stable throughout the experimental period (data not shown).
Cardiac function and injury during hypoxiareoxygenation
Severe normocapnic alveolar hypoxia resulted in cardiogenic shock within H-R groups with decreased cardiac index (CI) to 52 ± 1 % of baseline at 2 h (p \ 0.05, vs. sham-operated piglets) (Fig. 1a) . The CI recovered within 10 min of reoxygenation and then gradually deteriorated over 360 min of reoxygenation to 62 ± 5 % of baseline in the control group (Fig. 1a) . As shown in Fig. 1a , cyclosporine treatment significantly improved CI at 180, 240, and 300 min of reoxygenation. At 360 min of reoxygenation, CI was improved in early and delayed cyclosporine treatment (95 ± 4 and 79 ± 6 % of baseline vs. controls, p \ 0.05 and p = 0.1, respectively). As compared with delayed treatment group, the CI of the early cyclosporine treatment group was higher at 360 min of reoxygenation (p = 0.05).
There was no difference in heart rate between cyclosporine-treated and control groups at the end of hypoxia and throughout the reoxygenation period ( Supplementary  Fig. 1A) . All H-R groups had decreased stroke volume index after 2 h of hypoxia (p \ 0.05 vs. sham-operated group) (Supplementary Fig. 1B) . Early but not delayed cyclosporine treatment significantly improved stroke volume index compared to the control group at 360 min of reoxygenation (84 ± 6 and 77 ± 9 vs. 59 ± 7 % of baseline, respectively). There were no significant differences in MAP and pulmonary arterial pressure between H-R groups during reoxygenation (Supplementary Fig. 2) .
After 2 h of hypoxia and 360 min of reoxygenation, the left ventricle myocardial lactate levels of early and delayed cyclosporine-treated groups were lower than that of control piglets (both p \ 0.05) (Fig. 1b) . Further, there was significant negative correlation between CI at 360 min reoxygenation with left ventricle myocardial lactate level (r = -0.54, p \ 0.005) among all groups. There was no difference in histopathological scores among groups (data not shown). Control piglets received no cyclosporine (n = 8). Sham-operated piglets underwent no hypoxia-reoxygenation (n = 6) CsA cyclosporine A * P \ 0.05 versus normoxic baseline (RM ANOVA) and Sham piglets at end of hypoxia Systemic oxygen transport during hypoxia-reoxygenation Systemic DO 2 decreased significantly in all H-R groups (vs. sham-operated piglets) during hypoxia and normalized rapidly upon reoxygenation (Fig. 2a) . As reoxygenation continued, systemic DO 2 gradually deteriorated in the control group, but not in cyclosporine-treated groups (Fig. 2a) . At the early stage of reoxygenation, both control group and delayed cyclosporine treatment group had similar deterioration of systemic DO 2 . However, systemic DO 2 was modestly improved after receiving cyclosporine in the delayed treatment group (Fig. 2a) . The early cyclosporinetreated group had significantly higher systemic DO 2 at 300 and 360 min of reoxygenation than that of controls.
After 2 h of hypoxia, systemic VO 2 decreased significantly in all H-R groups (Fig. 2b) . Systemic VO 2 increased steadily following reoxygenation in the H-R groups reaching peak recovery at 60 min of reoxygenation. During the final 4 h of reoxygenation, there was gradual deterioration of systemic VO 2 in control piglets, whereas the systemic VO 2 was maintained in the early cyclosporine-treated piglets with significant differences noted at 300 min and 360 min of reoxygenation.
All H-R groups had significant metabolic acidosis (pH 6.98 ± 0.1) and elevated plasma lactate concentrations at the end of hypoxia (vs. sham-operated group, both p \ 0.05) ( Table 1 ). Both arterial pH and plasma lactate returned back to normal after 6 h of reoxygenation (Table 1 ). There was no significant difference between 
Mesenteric perfusion and intestinal injury during hypoxia-reoxygenation
Superior mesenteric artery flow index and DO 2 significantly decreased in all H-R piglets after 2 h of hypoxia. The mesenteric perfusion of all H-R groups recovered similarly in the first 60 min of reoxygenation. Thereafter, all H-R groups had steady deterioration of mesenteric perfusion throughout the remaining experimental period. The improvement in mesenteric perfusion of both cyclosporine-treated groups was modest but did not differ significantly from that of controls at 360 min of reoxygenation (SMA flow index 102 ± 13 and 80 ± 12 vs. 77 ± 20 % of respective baseline; SMA DO 2 88 ± 10 and 71 ± 12 vs. 71 ± 21 % of respective baseline). At 360 min of reoxygenation, the SMA DO 2 of delayed cyclosporine-treated and control groups, but not early cyclosporine-treated piglets, remained significantly different from their respective baselines.
The intestinal tissue lactate levels of both cyclosporine-treated groups were lower than that of control group (p \ 0.05) (Supplementary Fig. 3 ). Cyclosporine treatment attenuated the intestinal injury with lower Park's grade of early cyclosporine-treated piglets than that of controls (1.4 ± 0.6 vs. 4.9 ± 0.9, p \ 0.02), whereas the improvement by delayed cyclosporine treatment was modest (2.9 ± 0.7, p = 0.1) (Fig. 3) . Histological intestinal injury was positively correlated with intestinal lactate level (r = 0.42, p \ 0.03).
Discussion
This is the first study to demonstrate that both early and delayed cyclosporine treatment during the resuscitation of asphyxiated newborn piglets improves cardiac functional recovery and systemic oxygen transport. However, in comparison to delayed cyclosporine treatment, administering cyclosporine early during resuscitation of asphyxiated newborn piglets may offer marginally superior cardioprotection and it has the added benefit of attenuating intestinal injury.
In contrast to adult myocardial infarction secondary to coronary occlusion, newborn myocardium suffers from global hypoxic injury secondary to asphyxia. In adult animal models and pilot human trials [8, [15] [16] [17] , cyclosporine treatment is administered just prior to revascularization of the coronary arteries by percutaneous coronary intervention. In contrast, asphyxiated newborns are unique in that pretreatment is not directly feasible with the fetus in utero. Thus, timing of administration of resuscitative medication is restricted to post-delivery and insertion of intravenous access. We have previously demonstrated that cyclosporine treatment immediately following resuscitation with reoxygenation improves cardiac function [9] and attenuates intestinal injury [10] in asphyxiated newborn piglets. Consistently, we also observed improved cardiac function and reduced intestinal injury with early cyclosporine treatment in the present study.
Griffiths and Halestrap [18] observed significant improvement in left ventricular function and preserved ATP/ADP levels in isolated rat heart treated with cyclosporine. These authors suggested that the transition from reversible to irreversible myocardial injury might involve mitochondrial dysfunction related to the MPTP. In agreement, we also previously observed preserved cardiac mitochondrial morphology [9] and mitochondrial functional integrity (unpublished data) concurrently with improved cardiac function following early cyclosporine treatment during resuscitation of asphyxiated newborn piglets. This is consistent with improved myocardial contractile function in rabbits post-cardiac arrest [19] .
The role of MPTP in reperfusion injury of enterocytes is less well investigated. We previously observed preserved intestinal mitochondrial morphology with early cyclosporine treatment during resuscitation of asphyxiated newborn piglets [10] . Supportively, Madesh and Balasubramanian [20] also suggested that cyclosporine might protect enterocyte mitochondria from oxidative stress. In addition, enterocyte mitochondria have been shown to be sensitive targets of damage during ischemia-reperfusion [21] . However, to the best of our knowledge, the optimal timing of cyclosporine treatment has not been specifically assessed in adult or newborn intestinal ischemia-reperfusion models. We hereby showed that cyclosporine treatment attenuated intestinal H-R injury, which contributes to morbidity in up to 20 % of asphyxiated neonates, with significant improvements in perfusion, lactate, and histological features in early treatment.
Although the mechanism of the protective effects of cyclosporine remains unclear, we speculate that is related to the inhibition of MPTP opening which is activated by mitochondrial calcium overload, oxidative stress, mitochondrial depolarization, and adenine nucleotide depletion [22, 23] . In rabbits post-cardiac arrest, Cour et al. [19] reported in vitro attenuation of MPTP activation and preserved oxidative phosphorylation with cyclosporine treatment compared to placebo-treated controls. We previously observed concurrent increase in left ventricle lipid hydroperoxides and cytochrome c following H-R in newborn piglets, with attenuation of both these levels with early cyclosporine treatment [24] .
Although the formation of MPTP has been demonstrated to occur during reperfusion [25] , the exact duration of MPTP activation during reperfusion/reoxygenation remains unclear. In clinical practice, there may be a delay of up to 2 h before specialized NICU care is available. Therefore, determining the optimal timing of cyclosporine administration during resuscitation of asphyxiated newborn piglets would provide important information regarding the therapeutic window. Although early cyclosporine treatment is optimal, our results demonstrated that a benefit exists with delayed treatment compared to no treatment at all. Similar to our observations, Sullivan et al. [26] also reported that early cyclosporine treatment (15 min post injury) provided better neuroprotection than late treatment (24 h post injury) in rats following traumatic brain injury. By treating the mice with Debio-025 (non-immunosuppressive analogue of cyclosporine A) following myocardial infarction, Gomez et al. [27] suggested that limiting infarct size might be the best strategy to reduce postischemic cardiac failure and improve overall survival. Therefore, it is possible that modest improvement in cardiac function and myocardial oxygen transport with delayed cyclosporine treatment may lead to improved outcomes. However, further research is needed to substantiate these claims in the newborn population as well as the molecular mechanism and clinical implication of delayed administration.
Given the literature on adult and animal studies, we believe that clinical trials are needed to investigate if postresuscitation administration of cyclosporine is effective in reducing the mortality and morbidities in neonatal asphyxia while optimal timing, dosage, and single versus repeated doses are factored in the study design. Meanwhile, Fig. 3 Intestinal histology. Representative histological features (hematoxylin and eosin stain) for piglets in a sham-operated, b control, c early cyclosporine treatment, and d delayed cyclosporine treatment groups following 2 h hypoxia and 6 h of reoxygenation with early or delayed cyclosporine (10 mg/kg) treatment (n = 8 in each group). Control piglets received no cyclosporine (n = 8). Sham-operated piglets underwent no hypoxia-reoxygenation (n = 6). a Healthy intestinal specimen from sham-operated piglets (Park's grade = 1.7 ± 0.8) which shows an intact villous, finger-like morphology with viable enterocytes and no ischemia changes in the submucosal layers, including submucosa, muscularis propria, and tunica adventitia. b Control piglets (Park's grade = 4.9 ± 0.9) and reveals transmural necrosis with infarction of all layers of the bowel and formation of soma bullae in proximity and in the muscularis propria (arrows). c Early cyclosporine-treated piglets (Park's grade = 1.4 ± 0.6), and shows villous morphology with single cell necrosis and protein accumulation, with no abnormalities seen in the submucosal layers. d Delayed cyclosporine-treated piglets (Park's grade = 2.9 ± 0.7) and shows epithelial lifting along villous sides (arrows) indicating ischemia-related change of the subepithelial tightness, whereas the submucosal layers show no ischemia changes. Original magnification 9100 important limitations must be considered as well as a better understanding of the molecular mechanism of protective effects of cyclosporine. Firstly, the translation of animal studies to human infants is always challenging. However, newborn piglets are the most similar surrogate model for human newborns, with similar anatomy and physiology [28] . The reoxygenation protocol may not be appropriate in some neonates including those with ductal-dependent congenital heart lesions or delicate pulmonary-systemic shunt balance. Secondly, the acute setting of our swine model allows for only a limited time (8 h) of observation. Further investigations are necessary to determine whether improved cardiac recovery with early and delayed cyclosporine treatment will persist in the long term. Thirdly, there is a paucity of literature on the pharmacokinetics of cyclosporine in newborns, thus the therapeutic window and therapeutic index remain undefined. The delay in administration of resuscitative medication by the NICU team was estimated to be 2 h. This is an approximation based on our personal observations; however, the delay may be variable based on the regional resources available. Fourthly, we did not examine the effects of cyclosporine treatment on the immune system or the central nervous system. Although we did not observe deleterious changes in cerebral perfusion with cyclosporine treatment, our acute swine model limits the assessment of neurological function. Furthermore, future studies should address if repeated administration of cyclosporine in asphyxiated neonates during recovery is effective and safe.
In conclusion, this is the first study to demonstrate that early and delayed cyclosporine treatment during resuscitation improves cardiac recovery and myocardial oxygen transport in asphyxiated newborn piglets. However, early treatment with cyclosporine may offer superior cardioprotection and attenuates intestinal injury in H-R piglets.
